Proteogenomics: A Novel Method To Study Biologic Factors of Ovarian Cancer

Proteogenomics: A Novel Method To Study Biologic Factors of Ovarian Cancer
A recent study led by researchers at the Pacific Northwest National Laboratory (PNNL) and Johns Hopkins Medical Institutions (JHMI) demonstrated the usefulness of combining genomic and proteomic data known as proteogenomics to gain new insights about biological factors responsible for ovarian cancer. Results from the study, “Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer,” were published in

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *